Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Peripheral vascular disease severity impacts health outcomes and health-related quality of life in maintenance hemodialysis patients in the HEMO Study.

Liu T, Liang KV, Rosenbaum A, Stephenson R, Pike F, Weissfeld L, Unruh ML.

Nephrol Dial Transplant. 2012 Jul;27(7):2929-36. doi: 10.1093/ndt/gfr760. Epub 2012 Jan 23.

2.

Heart failure severity scoring system and medical- and health-related quality-of-life outcomes: the HEMO study.

Liang KV, Pike F, Argyropoulos C, Weissfeld L, Teuteberg J, Dew MA, Unruh ML.

Am J Kidney Dis. 2011 Jul;58(1):84-92. doi: 10.1053/j.ajkd.2011.01.029. Epub 2011 May 6.

3.

Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW, Satayathum S, Lameire N, Saito A, Akiba T, Jadoul M, Ginsberg N, Keen M, Port FK, Mukherjee D, Saran R.

Circulation. 2006 Oct 31;114(18):1914-22. Epub 2006 Oct 23.

4.

The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis.

Unruh ML, Newman AB, Larive B, Dew MA, Miskulin DC, Greene T, Beddhu S, Rocco MV, Kusek JW, Meyer KB; Hemodialysis Study Group.

J Am Geriatr Soc. 2008 Sep;56(9):1608-17. doi: 10.1111/j.1532-5415.2008.01849.x. Epub 2008 Aug 21.

PMID:
18721224
5.

Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study.

Delmez JA, Yan G, Bailey J, Beck GJ, Beddhu S, Cheung AK, Kaysen GA, Levey AS, Sarnak MJ, Schwab SJ; Hemodialysis (HEMO) Study Group.

Am J Kidney Dis. 2006 Jan;47(1):131-8.

PMID:
16377394
6.

Peripheral vascular disease and serum phosphorus in hemodialysis: a nested case-control study.

Boaz M, Weinstein T, Matas Z, Green, Smetana S.

Clin Nephrol. 2005 Feb;63(2):98-105.

PMID:
15730051
7.

The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients.

Gilbertson DT, Guo H, Arneson TJ, Collins AJ.

Nephrol Dial Transplant. 2011 Sep;26(9):2934-9. doi: 10.1093/ndt/gfq853. Epub 2011 Feb 11.

8.

Effect of vascular comorbidities on survival of type 2 diabetes patients on renal replacement therapy.

Kervinen M, Lehto S, Grönhagen-Riska C, Finne P.

Am J Nephrol. 2012;36(6):509-15. doi: 10.1159/000345143. Epub 2012 Nov 17.

PMID:
23171532
9.

Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe.

van de Luijtgaarden MW, Noordzij M, Stel VS, Ravani P, Jarraya F, Collart F, Schön S, Leivestad T, Puttinger H, Wanner C, Jager KJ.

Nephrol Dial Transplant. 2011 Sep;26(9):2940-7. doi: 10.1093/ndt/gfq845. Epub 2011 Feb 16.

10.

Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Lopes AA, Bragg-Gresham JL, Satayathum S, McCullough K, Pifer T, Goodkin DA, Mapes DL, Young EW, Wolfe RA, Held PJ, Port FK; Worldwide Dialysis Outcomes and Practice Patterns Study Committee.

Am J Kidney Dis. 2003 Mar;41(3):605-15.

PMID:
12612984
11.

Peripheral vascular disease-related procedures in dialysis patients: predictors and prognosis.

Plantinga LC, Fink NE, Coresh J, Sozio SM, Parekh RS, Melamed ML, Powe NR, Jaar BG.

Clin J Am Soc Nephrol. 2009 Oct;4(10):1637-45. doi: 10.2215/CJN.02220409. Epub 2009 Aug 13.

12.
13.

Influence of co-morbidity on health-related quality of life in patients treated with hemodialysis.

Stojanovic M, Ilic S, Stefanovic V.

Int J Artif Organs. 2006 Nov;29(11):1053-61.

PMID:
17160962
14.

Long-term modality-related mortality analysis in incident dialysis patients.

Lee CC, Sun CY, Wu MS.

Perit Dial Int. 2009 Mar-Apr;29(2):182-90.

15.

Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.

Ota T, Umeda H, Yokota S, Miyata S, Takamura A, Sugino S, Hayashi K, Ishiki R, Takeichi Y, Iwase M, Inagaki H, Murohara T.

Am Heart J. 2009 Jul;158(1):92-8. doi: 10.1016/j.ahj.2009.04.013.

PMID:
19540397
16.

[Peripheral vascular disease: prevalence, mortality and relationship with inflammation in hemodialysis].

Vega A, Pérez García R, Abad S, Verde E, López Gómez JM, Jofré R, Puerta M, Rodríguez P.

Nefrologia. 2008;28(3):311-6. Spanish.

17.
18.

Estimated glomerular filtration rate at reinitiation of dialysis and mortality in failed kidney transplant recipients.

Molnar MZ, Streja E, Kovesdy CP, Hoshino J, Hatamizadeh P, Glassock RJ, Ojo AO, Kalantar-Zadeh K.

Nephrol Dial Transplant. 2012 Jul;27(7):2913-21. doi: 10.1093/ndt/gfs004. Epub 2012 Apr 20.

19.

Effect of peripheral vascular disease on kidney allograft outcomes: a study of U.S. Renal data system.

Brar A, Jindal RM, Elster EA, Tedla F, John D, Sumrani N, Salifu MO.

Transplantation. 2013 Mar 27;95(6):810-5. doi: 10.1097/TP.0b013e31827eef36.

PMID:
23354295
20.

Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).

Martínez-Castelao A, Gòrriz JL, Garcia-López F, López-Revuelta K, De Alvaro F, Cruzado JM; Spanish CALVIDIA Study Group.

J Nephrol. 2004 Jul-Aug;17(4):544-51.

PMID:
15372417
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk